Shree Ganesh Remedies Ltd
BSE:540737
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shree Ganesh Remedies Ltd
BSE:540737
|
IN |
|
Delivery Hero SE
LSE:0RTC
|
DE |
|
Fleury Michon SA
PAR:ALFLE
|
FR |
|
M
|
Mangata Holding SA
WSE:MGT
|
PL |
|
NBT Bancorp Inc
NASDAQ:NBTB
|
US |
|
AudioEye Inc
NASDAQ:AEYE
|
US |
|
Wereldhave NV
AEX:WHA
|
NL |
|
Y
|
Yeni Gimat Gayrimenkul Yatirim Ortakligi AS
IST:YGGYO.E
|
TR |
|
T
|
TAV Havalimanlari Holding AS
IST:TAVHL.E
|
TR |
|
V
|
Visa Inc
SGO:V
|
US |
|
Quadient SA
F:NEQ
|
FR |
|
IWG Plc
LSE:IWG
|
CH |
|
C
|
Company K Partners Ltd
KOSDAQ:307930
|
KR |
|
Nemaura Medical Inc
OTC:NMRD
|
US |
|
Cigniti Technologies Ltd
NSE:CIGNITITEC
|
IN |
|
Trilogy Metals Inc
TSX:TMQ
|
CA |
|
Global Dominion Access SA
MAD:DOM
|
ES |
|
Alignvest Acquisition II Corp
TSX:SFC
|
CA |
|
Hills Ltd
ASX:HIL
|
AU |
Bankruptcy Probability
Shree Ganesh Remedies Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Shree Ganesh Remedies Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
|
Shree Ganesh Remedies Ltd
BSE:540737
|
5.8B INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
235.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Shree Ganesh Remedies Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Shree Ganesh Remedies Ltd has total debt of 278.7m INR. This includes both short-term (0 INR) and long-term (278.7m INR) debt.
You can find a full breakdown on its Balance Sheet.
